PolyNovo (ASX:PNV) Insider Acquires A$75,045.00 in Stock

PolyNovo Limited (ASX:PNV) insider David Williams acquired 50,030 shares of the company’s stock in a transaction that occurred on Monday, September 15th. The stock was bought at an average price of A$1.50 per share, with a total value of A$75,045.00.

David Williams also recently made the following trade(s):

• On Friday, September 12th, David Williams bought 61,335 shares of PolyNovo stock. The shares were acquired at an average cost of A$1.40 per share, with a total value of A$85,991.67.
• On Thursday, September 11th, David Williams purchased 31,000 shares of PolyNovo stock. The stock was purchased at an average cost of A$1.39 per share, with a total value of A$42,935.00.
• On Wednesday, September 10th, David Williams bought 37,000 shares of PolyNovo stock. The stock was bought at an average cost of A$1.41 per share, with a total value of A$51,985.00.

PolyNovo Stock Performance

The company has a current ratio of 3.41, a quick ratio of 1.58 and a debt-to-equity ratio of 21.32. The stock has a market capitalization of $1.30 billion, a P/E ratio of 247.31, a PEG ratio of 2.63 and a beta of 1.67.

PolyNovo Company Profile

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound.